| 1 |
DYAX CORP COM CVR |
1,500,000 |
21,090 |
3.25% |
|
|
| 2 |
ACCELERON PHARMA INC |
250,000 |
9,740 |
1.50% |
|
|
| 3 |
ACELRX PHARMACEUTICALS INC |
1,000,000 |
6,730 |
1.04% |
|
|
| 4 |
ADVAXIS INC COM NEW |
839,500 |
6,724 |
1.04% |
|
|
| 5 |
AGENUS INC |
800,000 |
3,176 |
0.49% |
|
|
| 6 |
AKEBIA THERAPEUTICS INC |
118,000 |
1,374 |
0.21% |
|
|
| 7 |
ALDER BIOPHARMACEUTICALS INC |
250,000 |
7,273 |
1.12% |
|
|
| 8 |
ALKERMES PLC |
450,000 |
26,352 |
4.06% |
|
|
| 9 |
APPLIED GENETIC TECHNOL CORP |
60,600 |
1,274 |
0.20% |
|
|
| 10 |
APTOSE BIOSCIENCES INC |
1,083,333 |
6,404 |
0.99% |
|
|
| 11 |
AQUINOX PHARMACEUTICALS INC |
300,000 |
2,250 |
0.35% |
|
|
| 12 |
ARDELYX INC COM |
1,053,500 |
19,901 |
3.07% |
|
|
| 13 |
ARRAY BIOPHARMA INC |
1,000,000 |
4,730 |
0.73% |
|
|
| 14 |
AUSPEX PHARMACEUTICALS INC |
100,000 |
5,248 |
0.81% |
|
|
| 15 |
AVALANCHE BIOTECHNOLOGIES IN |
65,000 |
3,510 |
0.54% |
|
|
| 16 |
Agile Therapeutics, Inc. |
150,000 |
921 |
0.14% |
|
|
| 17 |
BELLICUM PHARMACEUTICALS INCORPORATED |
60,000 |
1,382 |
0.21% |
|
|
| 18 |
BIOCRYST PHARMACEUTICALS |
800,000 |
9,728 |
1.50% |
|
|
| 19 |
BRISTOL MYERS SQUIBB CO |
5,000 |
3,700 |
0.57% |
|
|
| 20 |
BRISTOL MYERS SQUIBB CO |
250,000 |
14,758 |
2.28% |
|
|
| 21 |
CELGENE CORP |
300,000 |
33,558 |
5.17% |
|
|
| 22 |
CELLECTAR BIOSCIENCES INC |
530,000 |
424 |
0.07% |
|
|
| 23 |
CELSUS THERAPEUTICS PLC |
300,000 |
1,440 |
0.22% |
|
|
| 24 |
CERULEAN PHARMA INC |
450,000 |
2,799 |
0.43% |
|
|
| 25 |
CHIMERIX INC |
400,000 |
16,104 |
2.48% |
|
|
| 26 |
CHINA BIOLOGIC PRODS INC |
90,000 |
6,051 |
0.93% |
|
|
| 27 |
COHERUS BIOSCIENCES INC COM |
222,200 |
3,626 |
0.56% |
|
|
| 28 |
Cellectar Biosciences @4.68 8/ |
530,000 |
1,638 |
0.25% |
|
|
| 29 |
Curis, Inc |
600,000 |
900 |
0.14% |
|
|
| 30 |
DERMIRA INC COM |
200,000 |
3,622 |
0.56% |
|
|
| 31 |
DEXCOM INC |
200,000 |
11,010 |
1.70% |
|
|
| 32 |
DICERNA PHARMACEUTICALS INC |
200,000 |
3,294 |
0.51% |
|
|
| 33 |
EAGLE PHARMACEUTICALS INC COM |
400,000 |
6,200 |
0.96% |
|
|
| 34 |
EPIRUS BIOPHARMA |
75,000 |
425 |
0.07% |
|
|
| 35 |
FORWARD PHARMA A/S |
150,000 |
3,125 |
0.48% |
|
|
| 36 |
GALECTIN THERAPEUTICS INC COM |
312,000 |
1,083 |
0.17% |
|
|
| 37 |
GENVEC INC |
1,329,300 |
2,765 |
0.43% |
|
|
| 38 |
GLYCOMIMETICS INC |
472,300 |
3,401 |
0.52% |
|
|
| 39 |
HERON THERAPEUTICS INC COM |
700,000 |
7,042 |
1.09% |
|
|
| 40 |
IMMUNE DESIGN CORP |
140,000 |
4,309 |
0.66% |
|
|
| 41 |
KARYOPHARM THERAPEUTICS INC COM |
385,000 |
14,411 |
2.22% |
|
|
| 42 |
KERYX BIOPHARMACEUTICALS INCORPORATED |
1,000,000 |
14,150 |
2.18% |
|
|
| 43 |
KINDRED BIOSCIENCES INC |
350,000 |
2,608 |
0.40% |
|
|
| 44 |
KITE PHARMA INCORPORATED |
255,000 |
14,706 |
2.27% |
|
|
| 45 |
LIPOCINE INC NEW |
666,666 |
3,507 |
0.54% |
|
|
| 46 |
MINERVA NEUROSCIENCES INC COM |
175,000 |
1,054 |
0.16% |
|
|
| 47 |
NANOSTRING TECHNOLOGIES INC |
300,000 |
4,179 |
0.64% |
|
|
| 48 |
NEKTAR THERAPEUTICS COM |
450,000 |
6,975 |
1.08% |
|
|
| 49 |
NEUROCRINE BIOSCIE COM USD0.001 |
1,000,000 |
22,340 |
3.44% |
|
|
| 50 |
NEVRO CORP COM |
10,000 |
387 |
0.06% |
|
|
